<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>UC Davis: Judging Session</title>
        <link>https://video.igem.org/videos/watch/4f837a1d-955f-4498-97d5-11bfeee583e6</link>
        <description>Site localization is mediated by oligopeptides that bind to the Thomsen–Friedenreich antigen (TF) antigen, also known as Gal-GalNAc, a disaccharide overexpressed on the surface of CRC cells. The metabolite released is indole-3-lactic acid (ILA), which has been proven to minimize CRC cell proliferation. Finally, a kill switch mediated by an RNA thermometer prevents the engineered bacteria from surviving outside physiological conditions of the body. Our LBP serves as a foundation for future development.</description>
        <lastBuildDate>Fri, 20 Nov 2026 21:53:12 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>UC Davis: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/4f837a1d-955f-4498-97d5-11bfeee583e6</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=4f837a1d-955f-4498-97d5-11bfeee583e6" rel="self" type="application/rss+xml"/>
    </channel>
</rss>